'Last Shot' for Embattled Exeter Hospital

Cheryl Clark, for HealthLeaders Media , November 29, 2012

It may be the third and last strike for Exeter Hospital.

The 100-bed New Hampshire facility—now infamous for employing a hepatitis C–infected tech whose alleged proclivity to inject himself with syringes intended for patients resulted in his infecting some 32 people—failed to pass its third inspection in September.

A report on that survey visit indicates that many of the problems the hospital was told to correct in two earlier inspection surveys remain, including some dealing with essential infection control practices. The new report was released Wednesday by the federal Centers for Medicare & Medicaid Services and the state health department's Bureau of Licensing and Certification.

"They are still on a termination track," says John B. Martin, manager of the state bureau that helped CMS inspect the hospital. "They are out of compliance. As far as I know, this is their last shot. When we go back in to do our next follow-up inspection by the end of the year, they'll need to be in compliance."

Or else.

"I don't know what flexibility CMS has around this," Martin adds.

1 | 2 | 3 | 4

Comments are moderated. Please be patient.

1 comments on "'Last Shot' for Embattled Exeter Hospital"

Lisa Karakostas (11/30/2012 at 12:38 AM)
I suggest you do more research and tell the truth instead of writing such a biased, one sided, inflammatory, and misleading story. It is reprehensible you did not do due diligence prior to writing what amounts to nothing more than a tabloid type sensational piece of writing designed purely to discredit a health care organization that has been in existence for over 100 years and has repeatedly received accreditation and high quality marks from numerous regulatory agencies.




FREE e-Newsletters Join the Council Subscribe to HL magazine


100 Winners Circle Suite 300
Brentwood, TN 37027


About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2016 a division of BLR All rights reserved.